Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study

Launched by CAIJIE SHEN · Aug 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for a heart condition called paroxysmal supraventricular tachycardia (PSVT), which causes the heart to beat very fast for short periods. The researchers want to find out if a newer treatment called pulsed field ablation (PFA) is more effective and safer than the traditional method called radiofrequency ablation (RFA). To do this, they will look at the experiences of patients who had either treatment about a year ago and compare their outcomes.

To be eligible for this study, participants need to be between 18 and 80 years old and have PSVT symptoms, such as certain types of fast heart rhythms. They also must be willing to attend follow-up appointments over the next year for tests and evaluations. Participants will receive care and monitoring, and their progress will be tracked at several points over the year. It's important to note that people with certain heart conditions, previous surgeries, or specific health issues may not qualify for this trial. This study aims to provide valuable information about the best treatment options for PSVT.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with symptomatic PSVT including: atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular re-entrant tachycardia (AVRT);
• • 2. Age range: 18 years old ≤ age ≤ 80 years old, with no gender restriction;
• • 3. Willing to receive the examinations and testings during one year follow-up required by the protocol;
• • 4. Voluntary signed informed consent.
• Exclusion Criteria:
• • 1. Organic heart disease;
• • 2. History of cardiac surgery;
• • 3. Previous failed ablation of PSVT;
• • 4. Presence of any implants, such as a permanent pacemaker;
• • 5. Patients with invasive systemic infections or advanced malignant tumors;
• • 6. Contraindications for septal puncture or retrograde transaortic access surgery;
• • 7. Any condition that makes the use of heparin or aspirin inappropriate;
• • 8. Pregnant or lactating women;
• • 9. Inability to fully comply with the study procedures and follow-ups or to provide their own informed consent;
• • 10. Coexistence with other arrhythmias, such as atrial fibrillation.